Which condition is associated with the use of atypical neuroleptics?

The association between atypical neuroleptics and diabetes mellitus is well-documented in the medical literature. Atypical neuroleptics, also known as second-generation antipsychotics, are commonly used to treat various mental health disorders. However, one of the significant side effects of these medications is their potential to induce metabolic syndrome, which includes symptoms such as weight gain, insulin resistance, and ultimately, an increased risk of developing type 2 diabetes mellitus.

Studies have shown that patients taking atypical neuroleptics may experience changes in glucose metabolism and an increase in appetite, leading to weight gain, which is a major risk factor for diabetes. Medications such as clozapine, olanzapine, and risperidone have been particularly noted for these side effects. Monitoring blood glucose levels in patients on atypical neuroleptics is often recommended as part of their treatment plan.

The other conditions listed do not have a strong or direct association with atypical neuroleptics. While hypertension can be affected by various factors related to mental health treatment, it is not specifically tied to the use of these medications. Anemia and asthma also do not have established links to atypical neuroleptics in the same way diabetes